Real-world assessment of antiplatelet treatment therapies for acute coronary syndrome (ACS) patients in the United States in a nationwide Electronic Health Record in 2018-2020

Back

ESC Professional Premium Access

Real-world assessment of antiplatelet treatment therapies for acute coronary syndrome (ACS) patients in the United States in a nationwide Electronic Health Record in 2018-2020

Session: Real-world evidence in acute coronary syndromes (1)

Topic: Pharmacotherapy

Speaker: Mrs A. Kang (Princeton, US)

Event: ESC Congress 2023

Congress Presentation

Add to my library

About the speaker

Mrs Amiee Kang

Bristol Myers Squibb, Princeton (United States of America)

0 follower

6 more presentations in this session

Immediate, early and late ventricular fibrillation complicating acute myocardial infarction: insights from a real life registry

Speaker: Doctor O. Weizman (Boulogne Billancourt, FR)

In-hospital prognosis of recreational drug use in patients with acute ST-elevation myocardial infarction: insights from the ADDICT-ICCU study

Speaker: Doctor A. Clement (Paris, FR)

Improving myocardial infarction emergency care: a joint intervention study of the Berlin Brandenburg Myocardial Infarction Registry (B2HIR) and emergency medical services (QS-Notfall)

Speaker: Assistant Professor M. Stockburger (Nauen, DE)

Performance of the High-STEACS Early Rule-Out Pathway for High Sensitivity Cardiac Troponin T at 30-days in a US population

Speaker: Doctor B. Allen (Gainesville, US)

Adherence to guideline-directed medical therapy and 3-year clinical outcome following acute myocardial infarction

Speaker: Ms D. Hyun (Seoul, KR)

Access the full session

Real-world evidence in acute coronary syndromes (1)

Speakers: Mrs A. Kang, Doctor O. Weizman, Doctor A. Clement, Assistant Professor M. Stockburger, Doctor B. Allen...

Access

About the event

ESC Congress 2023

25 August - 28 August 2023

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources